Nathan Robert Wall | Medicine | Excellence in Research Award

Posted on by Cognitive Scientist Awards

Dr. Nathan Robert Wall | Medicine | Excellence in Research Award

Dr. Nathan R. Wall is an accomplished academic, biomedical researcher, and military officer. He is currently an Associate Professor of Medicine at Loma Linda University School of Medicine and holds multiple leadership roles in research, oncology education, and national defense. With advanced degrees in biology, cancer biology, and business administration, he has dedicated his career to cancer research and military medical operations. Dr. Wall has served in multiple deployments with the California Army National Guard, including missions in Afghanistan, Poland, and Iraq. His military and academic excellence is recognized through numerous awards and honors. Dr. Wall combines rigorous research in molecular medicine with a passion for leadership, education, and national service. His extensive experience in academia, clinical research, and military command uniquely positions him at the intersection of science and strategic operations, contributing to both medical advancement and national security.

Profile

Education 🎓

Dr. Nathan R. Wall is currently pursuing a Master of Strategic Studies at the U.S. Army War College (2024–2026). He earned his MBA with a focus in Management from the University of Redlands (2006–2008), and a Ph.D. in Cancer Biology from Wayne State University (1996–2000), where he also completed an M.S. in Molecular Biology and Genetics. Prior to that, he obtained an M.S. in Biology (1992–1995) and a B.S. in Biology with a minor in Chemistry (1987–1991) from Walla Walla College (now Walla Walla University). His graduate training included mentorship under leading scientists like Dr. Ayad M. Al-Katib and Dr. Joan M. Redd. Across disciplines—from molecular biology to strategic leadership—Dr. Wall’s education reflects a commitment to interdisciplinary excellence, equipping him with the skills to navigate both biomedical research and complex military operations with strategic insight.

Experience 👨‍🏫

Dr. Nathan R. Wall has held academic appointments at Loma Linda University since 2008, currently serving as Associate Professor of Medicine in the Division of Human Anatomy. He also directs Research and Development at the James M. Slater Proton Treatment & Research Center and is Oncology Thread Director at the School of Medicine. Previously, he served in the Department of Biochemistry and Center for Health Disparities. Since 2008, Dr. Wall has simultaneously served in the California Army National Guard, rising through the ranks and completing deployments to Afghanistan, Poland, and Iraq in key command roles. He has also contributed as a scientific advisor for biotech firms and participated in Department of Defense medical research review panels. His interdisciplinary experience spans military medicine, molecular oncology, academic leadership, and national defense, making him a unique leader who bridges science, strategy, and service.

Awards & Recognitions 🏅

Dr. Wall’s exemplary service has earned him numerous military and civilian accolades. These include the Bronze Star Medal, NATO Medal, Afghanistan Campaign Medal, Global War on Terrorism Service Medal, and the Honorable Order of Saint Martin. He’s received multiple Army Commendation and Achievement Medals, along with California-specific honors like the California Medal of Merit and Drill Attendance Ribbon with multiple stars. Notably, he was recognized as “Citizen Warrior of the Month” by California ARNG Magazine in August 2018. Dr. Wall has also been honored with plaques and certificates from NATO, Bulgarian Joint Forces, and various military medical programs. His academic achievements include tenure at Loma Linda University and leadership roles in key training inspections. These honors reflect his unwavering commitment to excellence, leadership in medical readiness, and profound impact in both academic and military sectors.

Research Interests 🔬

Dr. Wall’s research focuses on cancer biology, with specific expertise in molecular mechanisms of disease, targeted therapies, and translational oncology. His work bridges basic science and clinical application, especially in the context of proton therapy and health disparities in underserved populations. At Loma Linda University, he leads interdisciplinary teams addressing tumor microenvironments, cancer signaling pathways, and innovative therapeutics. Dr. Wall also contributes to Department of Defense research as a peer reviewer, ensuring scientific rigor in funded medical studies. His research often integrates his military background, exploring how stress and trauma-related factors influence cancer biology and immune responses. As Director of R&D at a leading proton treatment center, he’s advancing precision medicine in oncology. Dr. Wall’s work is marked by its practical implications, scientific depth, and commitment to improving patient care—particularly for populations affected by health inequities or involved in military service.

Publications

  • Seco-Duocarmycin SA in Aggressive Glioblastoma Cell Lines

    International Journal of Molecular Sciences
    2025-03-19 | Journal article
    DOI: 10.3390/ijms26062766
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Ryan N. Fuller; Antonella Bertucci; Amy Nguyen; Quanqing Zhang; Tobias Emge; Kristopher E. Boyle; Nathan R. Wall; Marcelo Vazquez

  • A Comprehensive Review of the Antitumor Properties and Mechanistic Insights of Duocarmycin Analogs

    Cancers
    2024-09-27 | Journal article
    DOI: 10.3390/cancers16193293
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Joab Galvan Bustillos; Ryan N. Fuller; David Caba Molina; Antonella Bertucci; Kristopher E. Boyle; Marcelo E. Vazquez; Nathan R. Wal

  • A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection

    Vaccines
    2023-12-18 | Journal article
    DOI: 10.3390/vaccines11121865
    CONTRIBUTORS: Béla Dénes; Ryan Fuller; Wayne Kelin; Tessa Levin; Jaipuneet Gil; Aaren Harewood; Márta Lőrincz; Nathan Wall; Anthony Firek; William Langridg

Jim Jinn-Chyuan Sheu | Precision medicine | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Jim Jinn-Chyuan Sheu | Precision medicine | Best Researcher Award

Dr. Jim Jinn-Chyuan Sheu is a professor at the Institute of Biomedical Sciences, National Sun Yat-sen University, Taiwan, and an adjunct professor in several prestigious institutions. With a PhD in Life Science from National Tsing-Hua University, his academic and industrial experiences span cancer genetics, precision medicine, and biopharmaceuticals. He has held positions at Johns Hopkins Medical Institutions and Development Center for Biotechnology. His research explores molecular mechanisms underlying diseases such as cancer and endometriosis, employing genome-wide technologies to identify biomarkers and drug targets. He actively contributes to biomedical innovation, translational medicine, and mentorship. Dr. Sheu has received numerous national and international awards, including the Wu-Da-You Memorial Award and Sigma Xi membership. He is also an ambassador for the European Association for Cancer Research. As a prolific researcher and reviewer, he plays key roles in research councils and institutional review boards, helping shape scientific policy and translational biomedical advancements in Taiwan and beyond.

Profile

Education 🎓

Dr. Sheu earned his Ph.D. in Life Science from National Tsing-Hua University, Taiwan, in 2002, where he focused on advanced molecular biology, gene expression regulation, and biomedical research. His doctoral training provided a strong foundation in cancer genetics and systems biology. Earlier, he completed his B.S. in Biology (now Life Science) from Fu-Jen University in 1994, building core competencies in biological sciences and cellular mechanisms. These educational milestones equipped him with theoretical knowledge and technical skills in genomics, proteomics, and cellular signaling, which are now reflected in his research on chromatin remodeling, cancer biomarkers, and therapeutic targets. Through rigorous academic mentorship, Dr. Sheu gained early exposure to multidisciplinary research and critical analysis, fostering his interest in precision medicine. His academic background laid the groundwork for his contributions to biomedical research, drug development, and translational science. These formative years in Taiwan’s top universities underpin his long-standing excellence in scientific discovery and innovation.

Experience 👨‍🏫

Dr. Sheu’s professional experience includes faculty roles and research leadership across academia and industry. He has served as a Professor at National Sun Yat-sen University since 2014 and previously held faculty roles at China Medical University. Internationally, he was a Research Fellow at Johns Hopkins Medical Institutions (2004–2006). Between 2003–2004, he worked in various leadership positions at the Development Center for Biotechnology, including Director of Protein Drugs Division and Project Leader. His postdoctoral and early research roles included work with Dr. Tse-Wen Chang and Dr. Carmay Lim at Academia Sinica. His academic leadership includes roles such as Associate VP of R&D, Chair of the Institute of Biomedical Sciences, and Director of Research Resources at NSYSU. He has reviewed research proposals for numerous hospitals and institutions, served on IRBs, and guided government research policy. His diverse experience bridges basic science, translational research, and biomedical entrepreneurship with national and global impact.

Awards & Recognitions 🏅

Dr. Sheu has received over 30 prestigious awards. In 2023 alone, he earned the Tien-Te Lee Award, NSYSU Outstanding Faculty Award, and top honors at the 37th Joint Biomedical Conference. He previously received the Prof. Chii-Ruey Tzeng Award, Sigma Xi membership (2021), and EACR Ambassador role (2020). His innovation was recognized by Future Tech Award and the 2020 Smart Life Innovation Competition. His studies were featured as Taiwan Research Highlights and F1000Prime recommendations. He was the 2014 recipient of the Wu-Da-You Memorial Award and the IBC Outstanding Scientific Achievement Award. He received the Medical Young Investigator Award in 2009 and the Best Basic Science Award at Johns Hopkins in 2005. As a government-financed scholar to the U.S., his academic excellence has been internationally recognized. He consistently ranks among Taiwan’s top biomedical researchers, illustrating his impact through award-winning research in endometriosis, cancer stemness, diagnostics, and therapeutic innovation.

Research Interests 🔬

Dr. Sheu’s research focuses on cancer genetics and genomics, endometriosis, precision medicine, chromatin remodeling, cytoskeletal dynamics, cell adhesion and invasion, and mechanotransduction. His lab investigates how abnormalities in gene expression and chromatin structure drive disease progression, especially in gynecologic cancers and endometriosis. By applying genome-wide analysis and bioinformatics, his team identifies disease-driving genes and develops novel diagnostic tools and therapeutic strategies. A key interest is the tumor microenvironment and how cytoskeletal networks and nuclear architecture influence cancer stemness and metastasis. His group explores traditional Chinese medicine compounds and stem cell therapies, advancing integrative approaches to medicine. Antibody and vaccine engineering are also integral to his translational pipeline. Funded by NSTC Taiwan and other institutions, his projects target non-invasive diagnostics and biomarker-based interventions. His long-term vision involves bridging molecular biology, clinical application, and therapeutic innovation to impact patient care and global health through interdisciplinary and precision-driven biomedical science.

Publications

Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Dr. Vahid Rashedi 👨‍⚕️, an esteemed Assistant Professor of Gerontology at the University of Social Welfare and Rehabilitation Sciences 🇮🇷, has made outstanding global contributions in aging, cognition, and psychogeriatrics 🌍🧠. With a Ph.D. in Gerontology (2017) 🎓 and extensive editorial duties across high-impact journals 📚, he’s actively involved as a Senior Collaborator with the Global Burden of Disease Project at IHME, University of Washington 🇺🇸. Recognized as a Top 1% scientist by Stanford University in 2024 🏅, he combines academic excellence, innovation, and impactful research. His interdisciplinary work spans gerontology, rehabilitation, mental health, and cognitive science, cementing his status as a global leader in aging research 🌐💡.

Profile

Education 🎓

Dr. Rashedi began his academic path with a Bachelor’s and Master’s degree in Rehabilitation Sciences 🎓🦾, focusing on geriatric care and assistive technology. He earned his Ph.D. in Gerontology with distinction in 2017 🥇, building expertise in psychogeriatrics, mental health, and cognitive decline. His academic training was rooted in interdisciplinary frameworks linking medicine, psychology, and social work 🔬💬. This diverse education empowered him to bridge clinical insights with research, enabling innovative health solutions for elderly populations 👵👴. He complements formal education with global scientific memberships and ongoing collaborations with prestigious institutes, such as IHME 🌎, emphasizing lifelong learning and cutting-edge research.

Experience 👨‍🏫

Dr. Rashedi has over a decade of rich academic and research experience, currently serving as Assistant Professor at the University of Social Welfare and Rehabilitation Sciences 🏫. Since 2019, he has been a Senior Collaborator at IHME, University of Washington, contributing to the Global Burden of Disease project 📊🌐. He has authored 126 indexed journal articles 📑, published a book 📖, and holds four patents, including rehabilitation innovations like the vibrating ankle-foot orthosis 🦿. He is a prolific editorial board member and associate editor for over 10 international journals 📘🖋️. His work in psychogeriatrics and cognition has garnered global recognition, highlighting his leadership and mentoring roles 👨‍🏫🏅.

Awards & Recognitions 🏅

Dr. Rashedi is recognized globally for his scientific excellence, notably ranked in the Top 1% of scientists worldwide by Stanford University in 2024 🌟📈. He holds editorial roles in Frontiers, CGJ, and the Journal of Gerontology, reflecting scholarly esteem 📚. He is a trusted reviewer for numerous high-impact journals and was honored with national and international awards 🥇. His patented inventions in geriatric rehabilitation demonstrate a blend of innovation and clinical value 💡🏥. His GSA, APA, and ISTAART memberships validate his international standing 👏🌐. These honors underscore his unwavering dedication to improving elderly lives through evidence-based science and collaboration 🤝

Research Interests 🔬

Dr. Rashedi’s research delves into psychogeriatrics, mental health, and cognitive disorders in aging populations 🧠👴. As part of the Global Burden of Disease team at IHME 🌍, he contributes to global health analytics, shaping international aging policies 📊. His innovations include assistive devices with therapeutic functions, bridging technology and clinical rehabilitation 🛠️⚙️. With 63 research projects and over 26,000 citations 🔍📈, his scholarly output is extensive and impactful. He leads investigations on dementia, geriatric depression, and cognitive resilience, supported by his roles in editorial boards and scientific societies 🧬📘. His mission is to translate research into real-world health solutions for aging communities 🌟🩺.

Publications 

Karin N Westlund | Chronic Pain Relief | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Karin N Westlund | Chronic Pain Relief | Best Researcher Award

Dr. Karin N. Westlund High is a distinguished neuroscientist and physiologist, currently a Distinguished Professor at UNM School of Medicine and a Research Physiologist at NM VA Health Care. 🇺🇸 She is recognized for her groundbreaking work in pain mechanisms and translational neurobiology. 📚 Her leadership as Vice Chair for Research and longstanding academic contributions span over four decades, advancing the fields of anesthesiology, neuroscience, and chronic pain treatment. 🧠💉

Profile

Education 🎓

Dr. Westlund High earned a B.A. (Zoology) 🎓 from the University of Texas at Austin (1975), followed by an M.A. in Zoology (1976). She received her Ph.D. in Physiology & Biophysics from UTMB Galveston in 1981. 🧪 During her graduate and postdoctoral years, she developed strong expertise in pain pathways and biophysics. 🧬 Her education laid a solid foundation for her influential career in academic medicine and neuroscience research. 📖🧠

Experience 👨‍🏫

From 1982 to the present, Dr. Westlund High has held key roles: tenured professor at UTMB Galveston, University of Kentucky, and UNM. 🏫 She was also Vice Chair for Research at UNM Anesthesiology (2017–2024) and served in VA medical systems in KY & NM. 🏥🧪 She led cell biology graduate programs, taught extensively in medicine and dentistry, and contributed to national research ethics. 🧑‍🏫🧠

Awards & Recognitions 🏅

Dr. Westlund High is the recipient of over 20 prestigious honors, including the Frederick W.L. Kerr Award (2008) 🏆, Innovator of the Year (2023), and multiple NIH awards. 💡 She’s been honored for teaching, research excellence, and innovation, including winning EQUALIZE Pitch Competition and a U.S. patent award (2025). 🇺🇸 She has served on editorial boards and grant panels globally, shaping pain research. 🌍🔬

Research Interests 🔬

Her research centers on pain neurobiology 🔍—investigating trigeminal nerve injury, chronic pain, neuroinflammation, and targeted therapeutic antibodies. 🧠💊 With deep NIH and VA support, she has led studies using translational animal models to discover novel pain relief methods. 🐭⚗️ Her work impacts both clinical and preclinical pain management, with over 40 years of translational insights and innovation. 💥📈

Publications 

  • Role of HDAC5 Epigenetics in Chronic Craniofacial Neuropathic Pain

    International Journal of Molecular Sciences
    2024-06 | Journal article | Author
    DOI: 10.3390/ijms25136889
    CONTRIBUTORS: Sifong Elise Hui; Karin N Westlund

  • Pluripotential GluN1 (NMDA NR1): Functional Significance in Cellular Nuclei in Pain/Nociception

    International Journal of Molecular Sciences
    2023-08 | Journal article | Author
    DOI: 10.3390/ijms241713196
    CONTRIBUTORS: Terry A. McNearney; Karin N Westlund

  • Rapid Generation and Molecular Docking Analysis of Single-Chain Fragment Variable (scFv) Antibody Selected by Ribosome Display Targeting Cholecystokinin B Receptor (CCK-BR) for Reduction of Chronic Neuropathic Pain

    International Journal of Molecular Sciences
    2023-07 | Journal article | Author
    DOI: 10.3390/ijms241311035
    CONTRIBUTORS: Adinarayana Kunamneni; Marena A. Montera; Ravi Durvasula; Dr Sascha Alles; Sachin Goyal; Karin N Westlund

Ali Osman | Life Science | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Ali Osman | Life Science | Best Researcher Award

👨‍🔬 Prof. Ali Osman Mohamed Osman Khalil is a distinguished biochemist specializing in agricultural sciences. 🎓 He earned his PhD in Biochemistry from Zagazig University, Egypt, in 2012. 🏫 Currently, he serves as a Professor at the Biochemistry Department, Faculty of Agriculture, Zagazig University. 📚 With over 130 international publications and an impressive h-index of 33 (Google Scholar), his research has significantly impacted agricultural biochemistry. 🏅 He has received prestigious awards, including the Egyptian State Prize for Encouragement in Agricultural Sciences (2014) and First Class Scientific Franchise from the President (2017). 🌱 His research focuses on environmentally friendly bioproducts, plant disease control, and biochemical applications in agriculture. 🌍 He is an active member of international scientific societies and serves as an external reviewer for renowned journals. ✨ Prof. Khalil has also collaborated on major scientific projects, contributing to advancements in biochemistry and sustainable agriculture.

Profile

Education 🎓

📜 Prof. Khalil holds a PhD in Biochemistry (2012) from Zagazig University, Egypt, with excellence. 🏆 His academic journey started with a B.Sc. in Agricultural Sciences-Biochemistry (2004), followed by an M.Sc. in Biochemistry (2008), both earned with distinction. 🎯 His studies focused on the biochemical mechanisms in agriculture, leading to his expertise in plant sterols, post-harvest protection, and biochemical applications in food science. 🔬 He has undertaken international fellowships, including INRA-France (2007-2008) and Umeå University-Sweden (2023-2024), enriching his research in clinical microbiology, infection, and immunology. 🌍 His educational background has provided a strong foundation for his pioneering research in agricultural biochemistry and food technology.

Experience 👨‍🏫

🔬 Prof. Khalil has over 20 years of academic experience at Zagazig University, Egypt. 📚 He began as a Teaching Assistant (2004-2008), then progressed to Assistant Lecturer (2008-2012) and Lecturer (2012-2017). 🎓 His expertise led to his promotion as an Assistant Professor (2017-2022) and later Professor (2022-present) in Biochemistry. 🏛️ His teaching covers biochemical applications in agriculture, plant metabolism, and molecular biochemistry. 🏅 He has supervised numerous postgraduate students, fostering the next generation of scientists. 🔍 As a principal investigator and collaborator in several international projects, he has worked on plant disease control, bioproduct development, and oxidation mechanisms. 📑 His editorial contributions include reviewing for top journals like LWT-Food Science and Technology, International Dairy Journal, and the African Journal of Agricultural Research. 🌍 His extensive research and teaching experience have solidified his reputation as a leading expert in biochemistry.

Awards & Recognitions 🏅

🎖️ Prof. Khalil has received numerous awards for his outstanding contributions to biochemistry and agricultural sciences. 🏅 In 2017, he was honored with the First Class Scientific Franchise by the Egyptian President for his scientific achievements. 🏆 He won the Egyptian State Prize for Encouragement in Agricultural Sciences (2014) and the Zagazig University Prize for Encouragement in Agricultural Sciences (2017). 🍏 His research excellence was recognized with the George Steno Award for Best Applied Research in Pomology (2017). 🌍 His global impact in plant biochemistry is further demonstrated by his international fellowships at INRA-France (2007-2008) and Umeå University-Sweden (2023-2024). 💡 As a member of esteemed scientific societies, including the American Chemical Society and Egyptian Botanical Society, he actively contributes to advancing agricultural research. 📚 His accolades reflect his dedication to innovation, sustainability, and scientific excellence in biochemistry

Research Interests 🔬

🌿 Prof. Khalil’s research primarily revolves around biochemical applications in agriculture, including post-harvest disease control, plant metabolism, and sustainable bioproducts. 🧪 His h-index of 33 (Google Scholar) and 132 SCOPUS-indexed publications highlight his impactful work. 🔍 As the Principal Investigator of projects like “Fighting Plant Fungi Post-Harvest Using Environmentally Friendly Bioproducts”, he explores innovative solutions for agricultural sustainability. 🌱 His research extends to plant sterol oxidation, polymerization, and antiviral strategies for plant protection. 📊 His expertise in biochemical pathways and molecular interactions has led to the development of novel biochemical strategies to enhance crop productivity and food safety. 🌍 His international collaborations, including a Spanish-Egyptian research project on molecular modeling, further advance his contributions to biochemistry, plant pathology, and environmental sustainability. ✨ His work bridges biochemistry and agriculture, making significant strides toward sustainable farming solutions

4Publications 

1. Eskandrani, A. A., Alsubaie, N., Bawahab, A. A., Abd-Elhakim, Y. M., Ibrahim, R. E.,
Khamis, T., Osman, A,… & Mohamed, A. A. R. (2025). Whey protein hydrolysate from
camel mitigates hypoxia-induced renal and gill damage in Nile Tilapia: Effects on stress, HIFα, apoptosis, inflammation, and metabolic pathways. Aquaculture, 742256.
2. Alsubaie, N., Mohamed, A. A. R., Metwally, M. M., Khamis, T., Osman, A., Alotaibi, B. S.,
… & Ibrahim, R. E. (2025). Alkalinity exposure induced growth inhibition, intestinal
histopathological changes, and down-regulated nutrient transporter expression in Nile Tilapia:
The ameliorative role of dietary camel whey protein hydrolysates. Comparative Biochemistry
and Physiology Part B: Biochemistry and Molecular Biology, 111074.
3. Alsubaie, N., Ibrahim, R. E., Bawahab, A. A., Mohamed, A. A. R., Abd-Elhakim, Y. M.,
Khamis, T., Osman, A., … & Ghannam, H. E. (2025). Ameliorative role of camel protein
hydrolysates diet against alkaline stress in Oreochrmis niloticus: Hematology, immune
responses and their regulating genes expression, and histopathological assays. Veterinary
Research Communications, 49(2), 79.
4. Dahran, N., Alotaibi, B. S., Abd-Elhakim, Y. M., Ibrahim, R. E., Metwally, M. M., Khamis,
T.,El-Far, A., Osman, A., … & Mohamed, A. A. R. (2025). Effects of camel whey protein
hydrolysate on growth, nutrient metabolism, and tight junction protein gene expression in
Oreochromis niloticus under hypoxia stress. Aquaculture International, 33(2), 137.
5. Elsheikh, M., Osman, A., Edris, S., Dawam, W., Sitohy, M., & Sabeq, I. (2024). Soybean
Glycinin’s Antibacterial Properties Provide a Feasible Natural Alternative for Improving the
Overall Quality and Shelf-Life of Beef Steaks and Combating Foodborne Pathogens. Food
and Bioprocess Technology, 1-16.
6. Amer, S. A., Ibrahim, R. E., Younis, E. M., Abdel-Warith, A. W. A., Osman, A., Davies, S.
J., & Shakweer, M. S. (2025). Potential of using kidney bean (Phaseolus vulgaris L) protein
hydrolysate as a plant protein supplement in Nile tilapia (Oreochromis niloticus) diets: effects
on growth, hematology, histology, and blood biochemical parameters. Aquaculture
International, 33(1), 95.
7. Amer, S. A., Behairy, A., Moustafa, A. A., Eltanahy, A., Younis, E. M., Abdel-Warith, A. W.
A., Osman, A., … & Tolba, S. A. (2024). Effects of dietary Arthrospira platensis phycocyanin
on growth, fatty acid assessment of breast muscles, hematobiochemical, immunological
responses, and hepatic histomorphology in broiler chickens. Journal of Applied
Phycology, 36(6), 3367-3380.
8. Ibrahim, R. E., Elshopakey, G. E., Aly, M. Y., Abdelwarith, A. A., Younis, E. M., AbdElhakim, Y. M., Khamis, T., Osman, A., … & Mohamed, A. A. R. (2024). Camel whey
protein hydrolysate diet mitigates alkaline stress–induced biochemical disorders and restores
the target of rapamycin, MAPK pathway, and autophagy-related gene expression in Nile
tilapia. Aquaculture International, 32(7), 9911-9932.
9. Sitohy, M., Enan, G., Abdel-Shafi, S., El-Wafa, N. A., El-Gazzar, N., Osman, A., & Sitohy,
B. (2024). Mapping pathogenic bacteria resistance against common antibiotics and their
potential susceptibility to methylated white kidney bean protein. BMC microbiology, 24(1),
49.
10. Amer, S. A., Rahman, A. N. A., ElHady, M., Osman, A., Younis, E. M., Abdel-Warith, A.
W. A., … & Ibrahim, R. E. (2024). Use of moringa protein hydrolysate as a fishmeal replacer
in diet of Oreochromis niloticus: effects on growth, digestive enzymes, protein transporters
and immune status. Aquaculture, 579, 740202.
11. Imbabi, T. A., El‐Sayed, A. I., Radwan, A. A., Osman, A., & Abdel‐Samad, A. M. (2024).
Prevention of aflatoxin B1 toxicity by pomegranate peel extract and its effects on growth,
blood biochemical changes, oxidative stress and histopathological alterations. Journal of
Animal Physiology and Animal Nutrition, 108(1), 174-184.

Haleh Ayatollahi | Health Informatics | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Haleh Ayatollahi | Health Informatics | Best Researcher Award

Dr. Haleh Ayatollahi is a professor of Medical Informatics at Iran University of Medical Sciences, specializing in health information management and digital health innovations. With a PhD in Health Informatics from the University of Sheffield, UK, she has extensive experience in academia and research. She currently serves as the Director of Deputy of Research and Technology at the School of Health Management and Information Sciences and the Health Management and Economics Research Centre. A key member of the Medical Informatics Evaluation and Examination Board, Dr. Ayatollahi has contributed significantly to the fields of eHealth, telemedicine, and health information systems. She has received multiple awards for her research, including the Best Researcher Award and the Khayam Award for a selected PhD thesis. Her work focuses on advancing digital healthcare solutions through innovative research and system evaluation. She actively mentors students and contributes to the global medical informatics community. 📚

Profile

Education 🎓

Dr. Haleh Ayatollahi holds a PhD in Health Informatics from the University of Sheffield, UK (2006-2010) 🎓. She earned her M.Sc. in Medical Records Education from Iran University of Medical Sciences (2000-2002) 📖, where she also completed her B.Sc. in Medical Records (1996-1998) and an Associate Degree in Medical Records (1994-1996) 🏥. Her academic journey has been marked by a strong focus on medical records, health informatics, and digital healthcare solutions. Through her education, she has gained expertise in health information systems, user-centered system design, and IT adoption in healthcare. Her advanced training has enabled her to contribute to numerous research projects, systematic reviews, and digital health innovations. With her extensive background in health informatics, she has played a key role in the development of medical information systems and telemedicine initiatives, making significant contributions to the field of healthcare technology. 🔬📊

Experience 👨‍🏫

Dr. Haleh Ayatollahi has held multiple leadership and academic roles in medical informatics and health information management. She is currently the Director of Deputy of Research and Technology at the School of Health Management and Information Sciences and the Health Management and Economics Research Centre at Iran University of Medical Sciences (2023-present) 🏥📊. She also serves as a member of the Medical Informatics Evaluation and Examination Board. Previously, she was the Postgraduate and Education Office Administrator (2014-2016) and a Teaching Assistant at the University of Sheffield (2009) 🎓. Her experience includes lecturing at Kashan University of Medical Sciences (2003-2005). She has played a key role in developing health informatics education, IT adoption strategies, and evaluating health information systems. With extensive contributions to academia and research, Dr. Ayatollahi continues to shape the future of digital healthcare through her leadership and innovative research. 💻📡

Research Interests 🔬

Dr. Haleh Ayatollahi’s research focuses on health data science, telemedicine, telehealth, mHealth, and eHealth 📊📡. She specializes in designing and evaluating health information systems, emphasizing user-centered approaches to improve digital healthcare solutions. Her work explores IT adoption and change management in healthcare, aiming to enhance system usability and efficiency. She is actively involved in systematic reviews and research on the integration of digital health technologies into clinical practice. Her studies contribute to improving electronic health records, decision support systems, and remote healthcare solutions. Through her expertise, she has advanced telehealth applications, ensuring seamless integration into medical practices. Her research has been widely published and presented at international conferences, making her a leading voice in health informatics. By combining technology and healthcare, she continues to shape the future of digital health and improve patient outcomes. 💡📚

Dr. Haleh Ayatollahi has received numerous prestigious awards for her contributions to health informatics. In 2025, she was honored with the Best Researcher Award at the International AI Data Scientist Awards 🏅. She has also won multiple thesis awards, including Best Thesis in Education and Research at the Vosough Festival (2023) 📖. She has been recognized with the Best Paper Presentation Award at various conferences, including the 9th National Burn Congress (2020) and the 5th IT Managers National Conference (2017) 🏆. Her research excellence was acknowledged with the Khayam Award (2019) and the Future Day Festival Award for a selected PhD thesis (2017). She received a full-time PhD scholarship from the Iranian Ministry of Health (2005) and a Research Excellence Grant from the University of Sheffield (2008) 🎓. Her accolades highlight her dedication to advancing digital health and medical informatics. 🔬📡

Publications 📚

Fan Zhang | Proteomics | Best Researcher Award

Posted on by Cognitive Scientist Awards

Dr. Fan Zhang | Proteomics | Best Researcher Award

Fan Zhang, born on September 23, 1991, is a postdoctoral researcher specializing in cancer proteogenomics 🔬. He is currently with the Department of Pathology at Duke University 🏛️. His research leverages mass spectrometry and bioinformatics 🖥️ to investigate metabolic pathways in therapy-resistant prostate cancer and other malignancies. He has received the FY23 Prostate Cancer Research Program Early Investigator Research Award 🏆 for his work on glutamine metabolism in advanced prostate cancer. His contributions to proteogenomics have resulted in multiple high-impact publications 📄 in Nature Communications, Cell Research, and Molecular & Cellular Proteomics. Proficient in LC-MS/MS, bioinformatics analysis, and experimental techniques, his research bridges the gap between basic cancer biology and clinical applications 🏥, paving the way for novel therapeutic strategies in oncology.

Profile

Education 🎓

Fan Zhang holds a Ph.D. in Biochemistry and Molecular Biology from Fudan University (2015-2020), where he focused on proteogenomic research. He further pursued postdoctoral training in Clinical Medicine at Fudan University (2020-2022) before joining Duke University as a postdoctoral researcher in the Department of Pathology in 2023. His academic journey began with a B.S. in Applied Biological Science from Anhui Agricultural University (2011-2015). Throughout his education, he gained expertise in genomics, transcriptomics, and proteomics, developing a strong foundation in bioinformatics and experimental methodologies. His interdisciplinary training has equipped him with skills in mass spectrometry-based proteomics, omics data analysis, and cancer metabolism research. His current research at Duke University focuses on metabolic vulnerabilities in prostate cancer, aiming to develop targeted therapies. His diverse academic background enables him to integrate various scientific disciplines, contributing significantly to cancer research and precision medicine.

Experience 👨‍🏫

Fan Zhang has extensive research experience in cancer proteogenomics. Currently a postdoctoral researcher at Duke University (2023-present), he investigates metabolic vulnerabilities in prostate cancer using advanced mass spectrometry and omics analysis. Previously, he was a postdoc in Clinical Medicine at Fudan University (2020-2022), where he contributed to proteogenomic studies on various cancers, including pituitary neuroendocrine tumors and diffuse large B-cell lymphoma. His Ph.D. at Fudan University (2015-2020) focused on proteogenomic characterizations of cancer, leading to high-impact publications. He is proficient in LC-MS/MS, bioinformatics, and experimental methodologies such as Western blotting, immunofluorescence, and cell culture. His research integrates mass spectrometry with genomics and transcriptomics to uncover novel therapeutic targets. With expertise in multi-omics data analysis, he has significantly contributed to the field of cancer biology. His work is supported by prestigious grants, highlighting his role as a leading researcher in proteogenomics and precision oncology.

Research Interests 🔬

Fan Zhang’s research focuses on proteogenomics and cancer metabolism, particularly in therapy-resistant malignancies like prostate cancer, pituitary neuroendocrine tumors, and diffuse large B-cell lymphoma. He specializes in mass spectrometry-based proteomics (DDA, DIA) and integrates multi-omics approaches, including genomics, transcriptomics, and metabolomics, to uncover novel cancer vulnerabilities. His current work at Duke University investigates glutamine metabolism in castration-resistant prostate cancer, aiming to develop targeted therapies. His expertise extends to bioinformatics analysis, large-cohort omics data interpretation, and advanced LC-MS/MS techniques for various biological samples. His research has led to multiple high-impact publications, highlighting his ability to translate complex molecular data into potential clinical applications. By combining experimental and computational approaches, he aims to identify biomarkers and therapeutic targets that can improve cancer treatment. His contributions to proteogenomics play a crucial role in advancing precision oncology and understanding the metabolic reprogramming of aggressive cancers.

 

Awards & Recognitions 🏅

Fan Zhang has received multiple awards and recognitions for his contributions to cancer proteogenomics. He was awarded the Fiscal Year 2023 (FY23) Prostate Cancer Research Program (PCRP) Early Investigator Research Award (2023-2025) for his project on targeting glutamine metabolism in advanced prostate cancer (Award Number HT9425-24-1-0237). His research has been recognized through multiple first-author and co-first-author publications in high-impact journals such as Nature Communications, Molecular & Cellular Proteomics, Cell Research, and The Prostate. His work has also been featured as a cover article in Cell Research (2022). His expertise in mass spectrometry, proteogenomics, and bioinformatics has positioned him as a leading young investigator in the field. In addition to research grants, he has received accolades for his innovative contributions to metabolic studies in oncology. His commitment to advancing cancer research has been instrumental in developing novel therapeutic strategies for therapy-resistant malignancies.

Publications 📚

Shilpa Kumari | Biotechnology | Best Researcher Award

Posted on by Cognitive Scientist Awards

Ms.Shilpa Kumari | Biotechnology | Best Researcher Award

 

Sharda University, India

Profile

Education

She is currently pursuing a Ph.D. at Sharda University since 2020, having completed her coursework with an impressive 84.5%. She holds an M.Sc. in Biotechnology from Chandigarh University, where she secured 79.6% in 2019. Prior to that, she earned her B.Sc. from HNB Garhwal Central University, Srinagar, in 2017 with a score of 66.7%. She completed her 12th grade in the Medical stream under CBSE in 2014 with 74.4% and her 10th grade in General Science in 2012, securing 75.5%.

 

Awards

She has been awarded the Sharda University Research Scholarship (SURS) by Sharda University since February 2021. She received a Silver Medal at the 8th Annual Meeting of the International Association of Zoologists and the 5th International Conference on Recent Trends in Life Sciences and Biotechnology held at Maharishi Markandeshwar (Deemed to be University), Haryana, in December 2024. Additionally, she was granted International Travel Support from the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India, to present her research at the University Malay, Kuala Terengganu, Malaysia, in August 2024. She secured 2nd Prize at the Anveshan International Convention 2023-2024 (North Zone), organized by the Association of Indian Universities (AIU) in January 2024. Furthermore, she won the Best Oral Presentation Award at the National Conference on Disease Diagnosis and Drug Development Against Human Pathogens, sponsored by DBT and organized by Muthyammal College of Arts and Science in November 2023.

Book chapters

1. Shilpa Kumari, Neha Verma, Anil Kumar, Sunita Dalal, and Kanu Priya. “Functional
overrepresentation analysis and their application in microbial pathogenesis.” In Systems Biology
Approaches for Host-Pathogen Interaction Analysis, pp. 171-179. Academic Press, 2024.
2. Neha Verma, Shilpa Kumari, Anil Kumar, and Kanu Priya. “Advancements in systems biologybased analysis of microbial pathogenesis.” In Systems Biology Approaches for Host-Pathogen
Interaction Analysis, pp. 181-190. Academic Press, 2024

Publication

Hongjun JIN | Nuclear Medicine Molecular Imaging | Interdisciplinary Innovation Prize

Posted on by Cognitive Scientist Awards

Prof Dr.  Hongjun JIN | Nuclear Medicine Molecular Imaging | Interdisciplinary Innovation Prize

: Sun Yat-sen University Fifth Affiliated Hospital, china

Profile

Education

Dr. Hongjun Jin is a Principal Investigator in Nuclear Medicine and a Doctoral Supervisor of Molecular Medicine at Sun Yat-sen University. He earned his PhD in Biochemistry from Texas A&M University in 2007, following a BS in Radiochemistry from Lanzhou University in 1994 and a BMed in Chinese Medicine from Beijing University of Chinese Medicine in 1997. He completed his postdoctoral training at PNNL from 2008 to 2012 and served as a radiology instructor at Washington University in St. Louis from 2012 to 2017. Since 2017, he has led the PET and radiochemical laboratory at his institute, having been recruited through Sun Yat-sen University’s “Hundred Talents Program.”

Research and Innovations:

1) General Research Fund for National Sciences Foundation of China (NSFC), 82372004,
“F-18 labelled PET probe targeting P2X7 receptor for Evaluation of Treatment for AD”
01/01/2024-12/31/2027￥480,000,
2) Key R&D project, 0007/2022/AKP, Macao S&T Fund (FDCT),“R&D of an Integrated
Molecular probe for Targeted TNFR2 New Tumor Diagnosis and
Treatment”,01/01/2024-12/31/2027,￥2,400,000 (out of ￥120,000,000)
3) Guangdong Provincial Enterprise Joint Fund, 2021A1515220004, Guangdong Province
“PET/MRI Neuromolecular Imaging Quantitative Study of New Drug Targeting Sigma1

Research Project

  • 1) Outstanding Foreign Young Scientist Talent Program, RFIS, 82150610508 NSF-CN，
    “ Establishment and drug evaluation of acetylcholinergic and dopaminergic
    neuromolecular probes (18F VAT and 18F-DTBZ) PET brain imaging quantitative
    system for Parkinson’s disease” 2022/01-2022/12，￥400,000
  • General Research Fund for NSFC, 81871382, “F-18 labelled PET probe targeting P2X7
    receptor for early detection of AD”01/01/2019-12/31/2022￥570,000
  • SYSU “Hundred Talent “Starting Fund (Period I)” SYSU-FA10/01/2017-09/30/2022
    ￥2,500,000
  • National Key R&D Program for Precision Medicine, 2018YFC0910601 Real-time, highdimensional, multi-modality imaging co-registration and theronoastic strategies for
    oesophageal squamous-cell carcinomas10/01/2018-12/31/2020￥1,272,500 (out of
    ￥19,230,000)
  • Sun Yat-sen University Military Industry Cultivation Project, 89000-18843403 SYSU
    “Key Technologies of Molecular Imaging of Immune Dysfunction in Microgravity
    Environment”, 2019/08-2021/12￥1,890,00
  • Researchers Initiate Clinical Research Project (IIT) Award, SYSU-FAH”A single-center,
    open, prospective assessment of the diagnostic significance of 18F-FDG PET/CT
    dynamic imaging and gene sequencing in detecting metastatic lesions of non-small cell
    lung cancer”,2020/10-2021/09￥50,000
  • COVID-19 infection prevention and control emergency S&T, ZH22036302200036PWC,
    Zhuhai City”Specific Targeting S- protein of SARS-CoV-2 PET molecular imaging
    probe”2020/08-2021/09,￥70,000

Citation Index:

Google Scholar Citations: 8684 (total) 7943 (since 2020)
h-index 26(total) 20 (since 2020)
i10-index 52(total) 39(since 2020)

Publications

Nuo Yu | Radiomics | Best Researcher Award

Posted on by Cognitive Scientist Awards

Ms. Nuo Yu | Radiomics | Best Researcher Award

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ,China

Nuo Yu is a Ph.D. candidate at the Cancer Institute and Hospital of the Chinese Academy of Medical Sciences, specializing in radiation oncology with a focus on esophageal squamous cell carcinoma (ESCC). His research primarily explores innovative chemoradiotherapy regimens to improve treatment outcomes for patients with locally advanced ESCC.

Yu has contributed to several peer-reviewed publications in SCI-indexed journals. Notably, he co-authored a study titled “Conversion Chemoradiotherapy Combined with Nab-Paclitaxel Plus Cisplatin in Patients with Locally Advanced Borderline-Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase I/II Prospective Cohort Study,” published in Strahlentherapie und Onkologie in August 2024. This research evaluated the efficacy and safety of a novel chemoradiotherapy regimen, demonstrating promising results in locoregional control and overall survival rates.

In March 2023, Yu co-authored another significant study, “Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic Study,” published in Current Cancer Drug Targets. This research focused on treatment strategies for elderly patients with ESCC, highlighting the potential benefits of combining chemoradiotherapy with nimotuzumab.

Yu’s work has been recognized at international conferences, including presentations at the American Society for Radiation Oncology (ASTRO), the Federation of Asian Organizations for Radiation Oncology (FARO), and the Korean Society for Radiation Oncology (KOSRO). These engagements underscore his active participation in the global radiation oncology community and his commitment to advancing cancer treatment research.

While still in the early stages of his career, Yu’s focused research on ESCC and his contributions to the field of radiation oncology position him as a promising candidate for the Best Researcher Award. Continued efforts to expand his research scope, increase publication impact, and assume leadership roles in larger-scale studies will further strengthen his candidacy.

Profile

Scientific Publications